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Kenneth Thorsen1,2, Jon Arne Søreide1,2 and Kjetil Søreide1,2*Abstract
Background: Patients with perforated peptic ulcer (PPU) often present with acute, severe illness that carries a high
risk for morbidity and mortality. Mortality ranges from 3-40% and several prognostic scoring systems have been
suggested. The aim of this study was to review the available scoring systems for PPU patients, and to assert if there
is evidence to prefer one to the other.
Material and methods: We searched PubMed for the mesh terms “perforated peptic ulcer”, “scoring systems”, “risk
factors”, ”outcome prediction”, “mortality”, ”morbidity” and the combinations of these terms. In addition to relevant
scores introduced in the past (e.g. Boey score), we included recent studies published between January 2000 and
December 2012) that reported on scoring systems for prediction of morbidity and mortality in PPU patients.
Results: A total of ten different scoring systems used to predict outcome in PPU patients were identified; the Boey
score, the Hacettepe score, the Jabalpur score the peptic ulcer perforation (PULP) score, the ASA score, the Charlson
comorbidity index, the sepsis score, the Mannheim Peritonitis Index (MPI), the Acute physiology and chronic health
evaluation II (APACHE II), the simplified acute physiology score II (SAPS II), the Mortality probability models II (MPM
II), the Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity physical sub-score
(POSSUM-phys score). Only four of the scores were specifically constructed for PPU patients. In five studies the
accuracy of outcome prediction of different scoring systems was evaluated by receiver operating characteristics
curve (ROC) analysis, and the corresponding area under the curve (AUC) among studies compared. Considerable
variation in performance both between different scores and between different studies was found, with the lowest
and highest AUC reported between 0.63 and 0.98, respectively.
Conclusion: While the Boey score and the ASA score are most commonly used to predict outcome for PPU
patients, considerable variations in accuracy for outcome prediction were shown. Other scoring systems are
hampered by a lack of validation or by their complexity that precludes routine clinical use. While the PULP score
seems promising it needs external validation before widespread use.
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Peptic ulcer disease is associated with potentially life-
threatening complications, including bleeding, perforation,
penetration and obstruction. Perforation is the second
most frequent complication after bleeding [1]. While the
clinical picture of patients with perforated peptic ulcer
(PPU) sometimes can be blurred by vague symptoms, most
PPU patients present with overt symptoms and signs of
peritonitis and eventually sepsis. Variations in the clinical* Correspondence: ksoreide@mac.com
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reproduction in any medium, provided the orpresentation as well as delay in diagnosis and work-up at
admission to the hospital, may potentially cause a worsen-
ing of symptoms and a deterioration of the clinical condi-
tion, with a detrimental outcome. Still, a high risk for
morbidity (20-50%) and mortality (3-40%) is encountered
in surgically treated PPU patients [2-7]. About every fifth
patient with PPU present with signs of sepsis and by a
careful preoperative assessment of the patients´ severity
grade, appropriate management can be offered to achieve
an optimal outcome of disease [8,9]. Currently, the ASA
score and the Boey score are the most frequently used
prognostic scoring systems in patients with PPU [10-14].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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intended for PPU patients in particular. Moreover, the ex-
ternal validation of the Boey score is uncertain.
The aim of this study was to review the available scoring
systems used for outcome prediction in PPU patients, and
to evaluate if any scoring system has advantages and pre-
dictive power to be preferred in clinical practice on this
group of patients.
Material and methods
We searched the Pub Med database by using the mesh
terms; “perforated peptic ulcer”, “scoring systems for mor-
bidity and mortality”, “risk factors”, ”outcome prediction”
and the combinations of these terms. In addition we did a
manual search from identified articles of relevance. We
evaluated studies on PPU patients and related outcomes
(morbidity and mortality), published in the English lan-
guage between 2000 and 2012, and recognized the scores
or combinations of scores that have been used in these
studies. A few seminal articles published before 2000 were
also taken into consideration. The study data were com-
pared by a descriptive approach.
Definitions
Receiver operating characteristics curve (ROC) is a stat-
istical method that measures diagnostic accuracy of a
test and offers graphical display of the true positives ver-
sus the false positives. Area under the curve (AUC) is
used to measure the “size” of the curve of prediction
composed by the graphic display between the ‘sensitivity’
and the ‘1–specificity’ relationship. AUC can range from
0.5 to 1.0 and a result of 1.0 indicates a perfect discrim-
inatory ability [15]. An AUC value > 0.8 is considered
good, a range between 0.60-0.80 is considered as moder-
ate, and an AUC value < 0.60 is regarded as poor [16].
The ROC curve is calculated by using all possible score
values as a potential cut-off value for a given outcome
prediction (such as mortality), and displays the optimal
cut-off point when sensitivity and specificity reaches an
optimum for both values, by which the point on the
ROC curved line is closest to the upper left corner on
the curve.
Results
Ten different scoring systems (Table 1) used for prediction
of outcomes for PPU patients were identified, including
the Boey score [14], the Hacettepe score [17] the Jabalpur
score [18], the Peptic Ulcer Perforation (PULP) score [19],
the American Society of Anesthesiologists (ASA) score
[20], the Charlson comorbidity index [21], the sepsis score
[22], the Mannheim Peritonitis Index (MPI) [23], the Acute
Physiology and Chronic Health Evaluation II (APACHE II)
[24], the Simplified Acute Physiology Score II (SAPS II)
[25], the Mortality Probability Models II (MPM II) [26]and the Physiological and Operative Severity Score for the
enumeration of Mortality and Morbidity physical sub-
score (POSSUM-phys score) [27]. In five studies, compari-
son of various scoring systems for outcome prediction
was done by ROC-analyses with reporting on the area
under the curve (AUC) [10,16,18,19,22]. A few studies
presented specificity and sensitivity, relative risks (RR) and
odds ratios (OR), while most studies reported on perform-
ance by calculation of the chi square test.
Scoring systems aimed at prediction of outcome in PPU
The Boey score was the first score directly aimed at
mortality prediction for perforated peptic ulcer [14]. The
original work by Boey et al stated that delay of surgery
after onset of symptoms for more than 48 hours, shock
upon admission and a high degree of comorbidity, were
associated with a 100% mortality when all factors where
present. Eventually, the delay of surgery was adjusted to
24 hours, and the scoring system was validated in a co-
hort from Hong Kong [14,28].
The Hacettepe score was also developed for PPU patients
and comprises four factors (Table 1) [17]. This study evalu-
ated 173 patients from Turkey and found the Hacettepe
score to be equivalent to the Mannheim Peritonitis
Index (MPI), with a sensitivity of 83% and specificity of
94% for mortality prediction. The sensitivity for the
MPI in this study was 75% and the specificity 96%.
Eventually, this score was used in a study from India,
as elaborated below [17,18].
The Jabalpur score was based on a study on 140 patients
from India, with a mean age of 39 years. This score takes
into account six factors, which are all assessable preopera-
tively. Both morbidity and mortality were predicted accu-
rately, based on a high AUC value (Table 2) [18].
Most recently, the Peptic Ulcer Perforation (PULP)
score has been introduced as a scoring system for perfo-
rated peptic ulcer. This score is based on a nationwide
study from Denmark and included 2668 PPU patients
with a median age of 70.9 years, where 55% was female.
Seven factors are taken into account, with weighted
points applicable for each factor, with a maximum sum
of 18 points being the highest possible. The optimal cut-
off point was found to be 7 points, which gives a positive
predictive value (PPV) of 25% for those with 0-7 points,
and a PPV of 38% for the group with 8 or more points
[19]. The PULP study also compared different systems
elaborated below.
General scores of comorbidity
The ASA score introduced in 1941 and intended for pre-
operative assessment of patients’ fitness level, is the oldest
available scoring system [20,29]. ASA score is frequently
reported together with other descriptive patient data
Table 1 Scoring systems used for outcome prediction in perforated peptic ulcer
Scoring systems
(reference)
Year of
report
Target
population
Outcome measured Parameters evaluated
Boey [14] 1987 Patients with
PPU
30 day mortality Presentation≥ or <24 hours; presence of preoperative shock;
level of comorbidity.
Hacettepe score
[17]
1992 Patients with
PPU
30 day mortality Presence of serious medical illness, acute renal failure,
white blood cell count, male gender
Jabalpur score
[18]
2003 Patients with
PPU
30 day mortality Time from perforation to operation, mean systolic blood
pressure preoperatively, heart rate, serum creatinine, age,
comorbidity
PULP [19] 2012 Patients with
PPU
30 day mortality Presentation≥ or <24 hours; presence of preoperative shock;
ASA score, presence of aids, active malignancy, liver failure;
serum creatinine > 130 mmol/l
ASA [20] 1941 General surgical
populations
Preoperative risk assessment
for surgical patients
Degree of comorbidity and present systemic disease
Charlson
comorbidity index
[21]
1987 General surgical
populations
Prediction of 1 year mortality
for hospitalized patients
Weighting of different comorbidities
Mannheim
peritonitis index
[23]
2002 General
peritonitis
Peroperative prediction of outcome
in patients with peritonitis
Age, gender, organ failure, duration of peritonitis,
site of perforation, diffuse peritonitis, level of exudate
APACHE II [24] 1985 Critically ill
patients
Prediction of outcome for
ICU patients
Aids, metastatic cancer, liver failure, immunosuppression,
chronic renal insufficiency, haemotologic malignancy,
lymphoma, leukemia, age, heart rate, systolic blood pressure,
respiratory rate, temperature, GCS, WBC, creatinine, blood gas,
potassium, sodium, patient origin
SAPS II [25] 1993 Critically ill
patients
Prediction of outcome for
ICU patients
Aids, metastatic cancer, haemotologic malignancy, age,
heart rate, systolic blood pressure, temperature, GCS,
urine output, WBC, bilirubin, urea, Potassium, sodium,
Patient origin
MPM II [26] 1993 Critically ill
patients
Prediction of outcome for
ICU patients
Metastatic cancer, liver failure, chronic renal insufficiency,
leukemia, age, acute renal failure, arrythmias, heart rate,
GI bleeding, GCS, intracranial mass effect, cerebrovascular
accident, cpr prior to admission, mechanical ventilation
POSSUM [37] 1991 Surgical patients Prediction of outcome
(mortality) for surgical
patients
Respiratory history; cardiac signs; age; heart rate;
systolic blood pressure; ecg; GCS; operative severity;
multiple procedures, total blood loss, peritoneal soiling,
finding of peroperative malignancy; elective or acute surgery,
WBC, Hb, urea, potassium, sodium
Peptic ulcer perforation score (PULP score).
American society of anesthesiologists (ASA) score.
Acute physiology and chronic health evaluation II (APACHE II).
Simplified acute physiology score II (SAPS II).
Mortality probability models II (MPM II).
Physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM) score.
Glasgow coma scale (GCS).
White blood cell count (WBC).
Gastrointestinal bleeding (GI bleeding).
Hemoglobin (Hb).
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but this classification has no specific role in outcome pre-
diction of patients with PPU per se.
The Charlson comorbidity index was developed to stra-
tify comorbidity into different risk groups by assigning
scores to various illnesses [21]. The Charlson index is a
widely used scoring system and considers 19 conditions
deemed clinically important, and they are each given 1 to
6 points due to high or low morbidity grade. Cerebrovas-
cular disease is given 1 point, severe liver disease 3 points
and metastatic cancer and AIDS are given 6 points. The
Charlson index was initially suggested for prediction oflong-term mortality. However, later studies have found it
to be useful also in prediction of in-hospital morbidity and
mortality [30,31]. One study also used the Charlson co-
morbidity index to predict outcome in PPU patients. A
highly significant association between a medium or high
Charlson score and 30-day mortality was observed, with
an odds ratio (OR) of 4.17 for high score (3 or more points
on the Charlson score) and an OR of 3.99 for medium
score (1-2 points on the Charlson score) [32]. However,
identification of any other PPU studies to confirm the
obtained results by use of this particular score was not
possible.
Table 2 Scoring accuracy of mortality prediction in PPU patients
Scoring systems
evaluated
Mishra et al [18] Lohsiriwat et al [10] Koc et al [16] Møller et al [19] Buck et al [22]
Mortality rate Mortality rate Mortality rate Mortality rate Mortality rate
10.7% 9.0% 10.6% 27.0% 17.0%
Area under the ROC Curve (AUC)
ASA 0.91 0.78 0.73
Boey 0.85 0.86 0.70 0.63
Apache II 0.87 0.76
SAPS II 0.86
MPM II 0.98
Hacateppe score 0.72
Jabalpur score 0.92
MPI 0.84
Modified Apache II 0.84
Modified MPI 0.85
PULP 0.83
Sepsis score 0.69
AUC denotes area under the curve . An AUC value > 0.8 is considered good, a range between 0.60-0.80 is considered as moderate, and an AUC value < 0.60 is
regarded as poor.
ASA, American society of anesthesiologists (ASA) score.
APACHE II denotes Acute physiology and chronic health evaluation II.
Modified APACHE II, APACHE II calculated when no available blood gas.
SAPS, Simplified acute physiology score II (SAPS II).
MPM, Mortality probability models II (MPM II).
MPI denotes Mannheim peritonitis index.
Modified MPI, MPI calculated when no available blood gas.
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and the presence of sepsis is fulfilled if two or more of the
following parameters are present, when infection is con-
firmed or highly likely; temperature >38°C or <36°C respira-
tory rate > 20 per minute or PCO2 < 4.3kPa, heart rate > 90
per minute, White cell count > 12.0×109 or < 4.0×109 [33].
Obviously this system is widely used in several aspects
of medicine, but has also been applied to predict out-
come in a PPU cohort, as elaborated below [22].
The Mannheim Peritonitis Index (MPI) consists of
seven factors that are more directly related to the opera-
tive findings. As the name implies, the design was speci-
fically intended for surgical patients presenting with
peritonitis. It comprises both preoperative and periope-
rative conditions, and has been found to predict morbi-
dity well, but less so in prediction of mortality for PPU
patients [10,23].
Intensive care unit (ICU) systems
The Acute physiology and chronic health evaluation II
(APACHE II) score is a common score globally and the
most used ICU scoring system in the USA. It comprises
twelve different physiological measurements, age and
previous health status, and was originally designed to
categorize ICU patients according to risk. The system
gives an increasing amount of points for extreme values
(high or low), between 0 (36.0°C -38.4°C) and 4 (≥41°C
and ≤29.9°C). Originally this score was found to performwell amongst ICU patients [24]. Later, it was also applied
to predict outcome in PPU patients. One study from the
USA [34] reported on zero mortality in PPU patients
with scores less than 11 points, and a 35% mortality rate
in patients with at least 11 points, which indicates this
as a useful cut-off. Others have tried different cut-off
values without finding these to be more useful. However
the APACHE II score is a rather complex system need-
ing mathematical equations to calculate and a minimum
of 24 hours to assess all factors. This may pose implica-
tions and concerns for its clinical usefulness and avai-
lability. Nevertheless, APACHE II has been shown to
predict outcome well also for PPU patients [16,24,34].
The Simplified acute physiology score II (SAPS II) is
designed for predicting outcome in ICU patients and
consists of 17 variables. It was developed in the 80s and
a revised version was introduced in 1993 [25]. The SAPS
II system is frequently used for outcome prediction in
critically ill patients in Europe and Scandinavia, and has
many similarities with the APACHE II system [25]. Both
systems are rather complex, with a number of factors
incorporated in the calculations, including physiologic
parameters. The SAPS II system predicts mortality and
morbidity well, but also seems more suitable for ICU pa-
tients. Nevertheless, this score performed well for out-
come prediction of PPU patients [16].
The Mortality probability models II (MPM II) was de-
signed for prediction of outcome in ICU patients. MPM II
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several related to systemic perfusion [26]. The MPM II pre-
dicted mortality better then both SAPS II and APACHE II
in one study [16]. However this study was rather small and
skewed with basically younger male patients, which is in
contrast to current PPU cohorts. While some studies from
Asia and Africa have presented similar patient characteris-
tics [35,36], recent studies from Scandinavia and Northern
Europe have presented data with a 1:1 male/female ratio
and median age close to 70 years [19,27]. Moreover, the
MPM II is a rather complex system, thus suboptimal for a
pre-operative calculation in the clinical context PPU pa-
tients present.
The Physiological and Operative Severity Score for Enu-
meration of Mortality and Morbidity (POSSUM score)
consists of 12 factors based on the patients physiological
state and 6 factors regarding operative conditions. These
factors are then entered into two mathematical equations
for risk assessment [37]. The POSSUM score was designed
for outcome prediction in ICU patients, and is widely used
in the UK. The original POSSUM score tended to over-
estimate mortality for low risk groups. The Portsmouth-
POSSUM (P-POSSUM) was therefore designed to adjust
for this [38]. Prediction of mortality in patients undergoing
emergency laparotomy was improved by the P-POSSUM
score, compared to the original POSSUM score [38,39].
The POSSUM-phys score, which is the physiologic sub-
score, comprises only the 12 physiologic parameters,
which can be assessed preoperatively. Only one study was
found that applied POSSUM-phys to PPU patients. In this
study 261 PPU patients with a mean age of 67 years were
evaluated and the POSSUM-phys score predicted both
mortality and morbidity [27]. The POSSUM-phys score, in
contrast to the POSSUM score, can be assessed pre-
operatively. However, with regard to PPU patients, we
have not encountered any studies comparing POSSUM-
phys score with other scoring systems.
Isolated risk factors for morbidity and mortality in PPU
In a large systematic review of pre-operative prognostic
factors in PPU patients, Møller et al identified 50 prog-
nostic studies evaluating overall 37 prognostic factors in
a population total of 29,782 patients [40]. They deemed
the overall methodological quality to be acceptable, yet
only two-thirds of the studies provided confounder-
adjusted estimates in the multivariable analyses. Very
few of the included studies investigated all, or the major-
ity of, the prognostic factors included in the review.
Some of the markers were only investigated in a few
studies, and overall, the diversity and spread across the
studies were considerable for most markers.
Nonetheless, adjusted pooled relative risks showed evi-
dence for an association between mortality and older
age, comorbidity, and the use of medications such asNon Steroid Anti Inflammatory Drugs (NSAIDs), ste-
roids and immunosuppressives [40]. Further predictive
factors associated with a poor prognosis included shock
upon admission, pre-operative metabolic acidosis, tachy-
cardia, elevated respiratory rate, acute renal failure, low
serum albumin level, high ASA score, and a pre-
operative time-delay >24 hours. Notably, several of the
scoring systems proposed (Table 1) include one or seve-
ral of these factors, but usually not all.
Studies comparing several scoring systems for outcome
prediction in PPU patients
Five studies were identified where AUC values were
compared between different scoring systems. Mortality
prediction varied from 0.63 to 0.98 for the different sys-
tems evaluated in these studies and these are presented
in Table 2 [10,16,18,19,22].
In another study from Chicago, including 436 PPU pa-
tients, the Boey score was compared to the APACHE II
score [41]. The Boey score predicted mortality, but failed
to predict morbidity. Moreover, the Boey score predicted
conversion from laparoscopy to laparotomy, with a con-
version encountered in 81.8% of Boey 2 score patients.
The APACHE II was found to predict both morbidity
and mortality. However, no AUC or relative risks were
calculated and of such it is not directly comparable to
other studies [41].
A report from Finland in the early 2000s included 280
PPU patients [23] and MPI predicted postoperative mor-
bidity better than both the ASA and the Boey score. But
the Boey score predicted mortality better than both the
ASA score and the MPI. The authors used likelihood ra-
tios to discriminate, but no AUC testing was done in this
study.
Accuracy of morbidity prediction
We identified only two studies that reported AUC
values for morbidity prediction [10,22]. Lohsiriwat et al
defined morbidity as some form of complication and
found AUC values of 0.80 for both the ASA and the
Boey score, while MPI performed poorest with an AUC
of 0.74 [10]. Buck et al defined septic shock and ICU
admission as secondary endpoints and found following
AUC values; for septic shock the AUC values were 0.67
for the ASA score, 0.72 for the Boey score, 0.74 for the
sepsis score and 0.78 for the APACHE II score. For
ICU admission the AUC values were 0.69 for the ASA
score, 0.64 for the Boey score, 0.72 for APACHE II
score and 0.64 for the sepsis score. Overall the APA-
CHE II performed best for prediction of the two chosen
secondary endpoints.
An overview of scoring systems, with mortality figures,
published in various studies since the year 2000, are pre-
sented in Table 3 [4,7,10,16,18,19,23,27,32,35,36,42-59].
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In this review we identified four scoring systems that have
been developed specifically for prediction of outcome in
PPU patients. However, several other general scores have
been applied on this particular group of patients, although
these scores have a non-specific design for PPU patients.
We also identified several factors that make direct com-
parison of results and pooling of patient populations for
assessment of outcome prediction difficult or impossible.
Among these obstacles are time and sociodemographic
differences and differences in score design and complexity.
Some factors of these barriers are further discussed below.
Implications of age on score performance
The Boey score was developed from a study population
with a median age of 51 years [14]. However, the age of
PPU patients in recent studies from Europe have been
considerably higher [19,27,43,45], and age has been shown
to be an isolated predictor for mortality in PPU patients
[4,19,40,43]. Also, in the identified studies on mortality of
PPU patients published the last decade, the 30 day mortal-
ity was at least 14% when age was mean or median > 60
years [4,19,27,32,43,45,48], in contrast to a decreased
mortality between 3% and 14% in patient series with a
mean or median age of < 60 years [7,10,16,23,36,44,47].
Hence, the Boey risk score may not be as suitable for
the older age groups as for the younger. As pointed out
by others [22], there is also a weakness in its crudeness,
including the definition of shock with a systolic blood
pressure < 90 mm Hg in the original study by Boey. In
contrast, shock is usually defined by a combination of
systolic blood pressure ≤100 mm Hg and tachycardia,
defined as a pulse ≥100 per minute [19,43]. Thus, the
Boey score may vary due to the definitions used. Never-
theless, several studies have found the Boey score to be
a good predictor of mortality in PPU patients [10,19,23].
The Boey score was specifically designed for PPU
patients, and while definitions are of some concern, the
simplicity makes it very quick to calculate which is an
advantage. Of note, the Boey score has not performed as
well in predicting morbidity [10,60,61].
Differences in sociodemographic regions
The Hacettepe score has been applied in two different
studies with varying results and not better than the
other systems used. It evaluates four factors and should
be feasible to assess. However, 77% of the patients
were < 50 years of age and 94% were men. Similar PPU
patient groups are found in other developing countries,
but the patient demography is quite different in non-
developing countries, with older age and minor differ-
ences between genders.
The Jabalpur score performed a high AUC score in the
only study reporting it [18]. But the patient group wasamong the youngest with a mean age of 39 years with
98% males. Therefore, it seems more applicable in re-
gions with similar demography. When these two systems
were tested in cohorts in India and Turkey, the Jabalpur
system performed superior to the Hacettepe score
[17,18].
The nationwide PULP study is the largest recent study
evaluating outcome prediction for PPU patients. Hence
the external validity may be stronger, at least for com-
parable, western populations with demography similar to
Denmark. The PULP score incorporates both the ASA
score and the Boey score and can be evaluated pre-
operatively. Since it does incorporate both these systems,
one would expect the PULP score to perform at least as
well as the other systems on their own. Indeed, the
PULP score did perform somewhat better, with slightly
higher AUC values than both the ASA score and the
Boey score in predicting morbidity and mortality [19].
However a validation of this system is needed.
Furthermore, the PPU systems found in the literature
and presented in this review differ in many ways. The
Boey score [14]was originally done on American patients
in the early 80s, the Hacettepe score [17] on a Turkish
population in the early 90s, the Jabalpur score [18] on
an Indian population in the early 2000s and the PULP
score [19] in Denmark in the late 2000. These studies
differ in geography, mean age and decade presented,
which means that further validation is recommended be-
fore any scoring system can be applied to a cohort diffe-
rent from the population of development.
Comparing AUC values
When comparing AUC values from ROC analyses from
different studies, several limitations have to be consi-
dered. For one, different inclusion criteria and patient
characteristics will potentially bias direct comparison of
AUC values among studies. Hence, comparing ROC
curve analysis and AUC values is best done on the same
mix of patients [62]. A prediction model is made from
fitting the data in a patient series by the means of logis-
tic regression. Data included in such models may differ
between studies, which may hamper comparison of AUC
values of scoring systems from different studies.
Second, the number and the ratio of outcome events
to the study population will influence the AUC accuracy
and its precision. The PULP study included 2668 pa-
tients and with a mortality rate of 27% (n = 720 patients)
as the evaluated outcome. Too few such outcome events
in any given study will make logistic regression problem-
atic and unreliable, with the confounding factors having
a greater influence and thus a bias on the results. As a
comparably large sample size, the PULP study may have
higher power and reliability, than the other four studies
comparing AUC values. However, the patient charac-
Table 3 PPU studies reporting on 30-day mortality
Study (reference) Country Study
period
Number of
patients
Mortality rate,
n (%)
Age, mean Score system used
Arici et al [50] Italy 1991-2004 147 14% 52 (median) Boey
Arveen et al [36] India 2006-2008 328 9% 43 ASA
Bae et al [7] Korea 2006-2007 4258 3% 74% younger than
60 years of age
No score system
Bas et al [51] Belgium 1998-2004 97 5% 39 No score system
Bin-Taleb et al [52] Yemen 1997-2006 156 4% 39 No score system
Chalya et al [56] Tanzania 2006-2011 84 11% 28 (median) No score system
Christensen et al [2] Denmark 1991-2003 2061 25% 61% older than
65 years of age
No score system
Dakubo et al [35] Ghana 1998-2002 326 11% 41 No score system
Egberts et al [27] Germany 1993-2005 261 24% 67 (median) Possum-phys
Forsmo et al [46] Norway 1992-2003 102 22% 71 (median) ASA
Hemmer et al [43] The
Netherlands
2000-2005 272 16% 62 ASA
Kamani et al [57] Iran 1996-2005 56 5% 50 No score system
Kim et al [49] Korea 2005-2010 142 6% 57 ASA
Koc et al [16] Turkey 2005-2006 75 11% 44 (median) APACHE II, APACHE III SAPS II,
MPM II
Kocer et al [47] Turkey 2001-2004 269 9% 43 ASA
Kujath [48] Germany 1996-2000 102 14% 69 ASA
Larkin et al [45] Ireland 1998-2007 76 20% 60 ASA
Lohsiriwat et al [10] Thailand 2001-2006 152 9% 52 Boey, ASA, MPI
Makele et al [23] Finland 1979-2000 280 14% 58 Boey, ASA, MPI
Mishra et al [18] India 1999-2001 140 11% 39 Apache II
MPI
Jabalpur
Montalvo-Jave et al
[53]
Mexico 2006-2008 30 17% 57 No score system
Muslu et al [58] Turkey 1998-2005 126 4% 51 No score system
Møller et al [19] Denmark 2003-2009 2668 27% 71 (median) PULP, ASA, Boey
Nasio/Saidi [59] Kenya 2005-2006 44 9% 35 No score system
Noguiera et al [44] Portugal 1990-2000 210 10% 53 (median) No score system
Rajesh et al [55] India 2006-2011 180 13% <50 years Apache II
Boey
Subedi et al [54] Nepal 2002-2004 145 7% 46 No score system
Taha et al [32] Scotland 1997-2006 270 19% 64 (median) Charlson comorbidity index
Thorsen et al [4] Norway 2003-2009 114 16% 67 (median) ASA
Boey
Table sorted alphabetically by study author’s name.
Mortality rates and age are rounded up/down.
American society of anesthesiologists (ASA) score.
Acute physiology and chronic health evaluation II (APACHE II).
Simplified acute physiology score II (SAPS II).
Mortality probability models II (MPM II).
Mannheim peritonitis index (MPI).
Peptic ulcer perforation (PULP) score.
Physiological and operative severity score for the enumeration of mortality and morbidity physical sub-score (POSSUM-phys score).
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dies, which may influence the external validity. Thus,
this model may not necessarily work well for other co-
horts, and should thus be tested externally.
Lastly, timing of collection of the score variables is an-
other important issue to consider when a scoring system
for outcome prediction should be chosen. The more infor-
mation that is available, the better would the performance
of the score be expected. Hence a post-operative score
would likely perform better as compared to a pre-operative
or a peri-operative scoring system.
Complexity of scores
The ASA score is in contrast to the ICU systems simple
to calculate, and it has been shown in various studies to
predict both morbidity and mortality in general surgical
patients [10-13,19]. Even though the ASA score neither
was designed for, nor solely functions as a PPU score, it is
widely used in PPU studies evaluating outcomes [4,10,19].
The ASA score has been shown to predict mortality well
in several groups of patients, included for PPU patients
[10,18,19,47]. The AUC values reported vary from 0.73 to
0.91, but the vast majority does not report AUC values or
other parameters that make it possible to compare diffe-
rent studies. The main problem of the ASA score has been
the inter-observer variability [63,64].
The MPI is a more complex system and must be ob-
tained during or after surgery, which is regarded challen-
ging. However it has been shown to predict both morbidity
and mortality, although to a varying degree. Only one study
reported an AUC value for MPI (0.84), which is considered
good [16], but both the ASA score and the Boey score
performed better in this study [10].
Four ICU systems that were developed for outcome pre-
diction of critically ill patients have been applied to PPU
patients in one or more studies. In addition one study
used the Charlson comorbidity index. But the complexity
of these systems seems to limit the implementation in a
general clinical setting. The APACHE II score is most fre-
quently reported, but is still no common system used for
PPU patients in general. They have all been shown to pre-
dict outcome for PPU patients, but to varying degree. And
since only the fewest studies actually report on AUC
values or other values that can be compared to others,
data are sparse. MPM II performed the highest AUC value
of all the scoring systems regarding mortality prediction
with 0.98, which is nearly perfect. However, this study was
small and skewed, with mostly younger male patients,
with a low mortality rate. Hence, its validity to patients
with a different age and demographic patterns is highly
questionable.
The Sepsis score has an important status in emergency
medicine and is easy and rapid to calculate. Early recog-
nition of the systemic inflammatory response syndrome(SIRS) and prompt goal directed therapy, including peri-
operative and postoperative, can be of paramount im-
portance and may influence outcome [9,33]. Probably,
treatment delay in PPU patients, one of the factors in
both the Boey score and the PULP score, is actually a
surrogate marker for imminent sepsis. Also the presence
of electrolyte disturbances, hypoalbuminemia, anemia,
kidney failure, leukocytosis and shock can all be seen as
part of the sepsis syndrome in a condition like perfo-
rated peptic ulcer. The sepsis score has also been found
to predict outcome in PPU patients, but less so than
most of the other scores evaluated [22].
Conclusions
While no scoring system was ideal and all were ham-
pered by certain limitations, a few scores appeared easily
applicable in clinical practice. The Boey score and the
ASA score are most commonly applied in the current
literature to predict outcomes for PPU patients, but both
demonstrate variable accuracy. While the PULP score
seems promising, a validation is pending before a general
application can be recommended.
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